MENU CATEGORIES

Connect with us

Submit a Tip
MENU CATEGORIES
Posts Tagged with "wafaa el-sadr"

Thursday was a big day for Low. First, it played shelter to Harry Potter-cum-Allen Ginsberg. Then just a few hours later, it hosted the University Lecture starring Wafaa El-Sadr, Director of the Global Health Initiative at Mailman School of Public Health here at Columbia. Her lecture entitled, “The HIV/AIDS Epidemic: Global Tragedy, Lasting Triumphs,” traced […]

Read More

Today, the MacArthur Foundation announced this year’s recipients of its famed Genius Grants, and one winner is the Mailman School’s own Wafaa El-Sadr. El-Sadr is a clinical researcher, specializing in such noble pursuits as studying alternative treatments for patients who can’t tolerate certain therapies and developing gels that inhibit HIV transmission. She is also chief […]

Read More

Have Your Say

Prettiest blooms on campus in the spring?

View Results

Loading ... Loading …

Recent Comments

Cowardice. CU admins today are just like Grayson Kirk of yesteryear. A bunch of hirelings. alumna (read more)
Mayor Eric Adams, NYPD, And Columbia University Professors Hold Press Conferences Regarding Recent Student Arrests
April 19, 2024
good work Bwog. even and timely reporting on a very difficult issue (read more)
Students Protest Arrest Of Encampment Demonstrators On Butler Lawns
April 19, 2024

Comment Policy

The purpose of Bwog’s comment section is to facilitate honest and open discussion between members of the Columbia community. We encourage commenters to take advantage of—without abusing—the opportunity to engage in anonymous critical dialogue with other community members. A comment may be moderated if it contains:
  • A slur—defined as a pejorative derogatory phrase—based on ethnicity, race, gender, sexual orientation, ability, or spiritual belief
  • Hate speech
  • Unauthorized use of a person’s identity
  • Personal information about an individual
  • Baseless personal attacks on specific individuals
  • Spam or self-promotion
  • Copyright infringement
  • Libel
  • COVID-19 misinformation